Cleared Traditional

K183493 - SelectSite C304-HIS Deflectable Cathete...

K183493 is the FDA 510(k) clearance for SelectSite C304-HIS Deflectable Cathete... by Medtronic, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K183493 · Medtronic, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
88d
Days
Class 2
Risk

K183493 is an FDA 510(k) clearance for the SelectSite C304-HIS Deflectable Catheter System. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Medtronic, Inc. (Galway, IE). The FDA issued a Cleared decision on March 15, 2019 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic, Inc. devices

Submission Details

510(k) Number K183493 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 17, 2018
Decision Date March 15, 2019
Days to Decision 88 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 125d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K183493.
Telescope Guide Extension Catheter
K183353 · Medtronic, Inc. · Mar 2019
Ballast 088 Long Sheath
K182918 · Balt USA, LLC · Mar 2019
Route 92 Medical Delivery Catheter
K190431 · Route 92 Medical, Inc. · Mar 2019
MAMBA and MAMBA Flex Microcatheters
K190401 · Boston Scientific Corporation · Mar 2019
Venture 0.014 Catheter
K182570 · Vascular Solutions, LLC · Mar 2019
AXS Catalyst Distal Access Catheter 068 x 115cm, AXS Catalyst Distal Access Catheter 068 x 125cm, AXS Catalyst Distal Access Catheter 068 x 132cm
K183463 · Stryker · Mar 2019